SANDRA HARPER: Open Payments
NPI 1467951822 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 22 payments from 9 companies in 2025. Trend: 2023 $24 · 2024 $172 · 2025 $451
Food & beverage: $437Education: $14
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $75 |
| Travere Therapeutics, Inc. | 5 | $64 |
| Ardelyx, Inc. | 3 | $60 |
| Novo Nordisk Inc | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Calliditas Therapeutics US Inc. | 1 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
Products named: TAVNEOS, IBSRELA, TARPEYO, JARDIANCE, Ozempic, VOYXACT, Wegovy, TUDORZA PRESSAIR.
Industry payments across TN — which companies pay providers there.
